Correlation Between Morgan Stanley and Medical Marijuana

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Medical Marijuana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Medical Marijuana into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Medical Marijuana I, you can compare the effects of market volatilities on Morgan Stanley and Medical Marijuana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Medical Marijuana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Medical Marijuana.

Diversification Opportunities for Morgan Stanley and Medical Marijuana

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Morgan and Medical is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Medical Marijuana I in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Marijuana and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Medical Marijuana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Marijuana has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Medical Marijuana go up and down completely randomly.

Pair Corralation between Morgan Stanley and Medical Marijuana

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.08 times more return on investment than Medical Marijuana. However, Morgan Stanley Direct is 12.64 times less risky than Medical Marijuana. It trades about 0.14 of its potential returns per unit of risk. Medical Marijuana I is currently generating about -0.06 per unit of risk. If you would invest  1,929  in Morgan Stanley Direct on September 26, 2024 and sell it today you would earn a total of  172.00  from holding Morgan Stanley Direct or generate 8.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy98.44%
ValuesDaily Returns

Morgan Stanley Direct  vs.  Medical Marijuana I

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Medical Marijuana 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medical Marijuana I has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Morgan Stanley and Medical Marijuana Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Medical Marijuana

The main advantage of trading using opposite Morgan Stanley and Medical Marijuana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Medical Marijuana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Marijuana will offset losses from the drop in Medical Marijuana's long position.
The idea behind Morgan Stanley Direct and Medical Marijuana I pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal